| 1 | L-Histidine | 71-00-1 | Core raw material for peptide synthesis, pharmaceutical intermediates and biochemical experiments. |
| 2 | D-Histidine | 351-50-8 | Chiral drug development and preparation of specialized biochemical reagents. |
| 3 | DL-Histidine | 4998-57-6 | General scientific research experiments and basic formulation raw materials. |
| 4 | L-Histidine Hydrochloride Monohydrate | 5934-29-2 | Pharmaceutical preparation and high-efficiency buffer preparation. |
| 5 | D-Histidine Hydrochloride | 1007-42-7 | Chiral reagent and special process development. |
| 6 | DL-Histidine Hydrochloride | 6459-59-2 | Universal scientific research reagent and formulation raw material. |
| 7 | L-Histidine Sulfate | 142-82-5 | Biochemical experiments and accurate enzyme activity determination. |
| 8 | Aminoalcohol | 70142-15-3 | Pharmaceutical intermediate synthesis and special biochemical research. |
| 9 | L-Aminool Dihydrochloride | 1596-64-1 | Pharmaceutical synthesis process and supporting research reagents. |
| 10 | D-Aminool Dihydrochloride | 75614-84-5 | Chiral drugs and specialized reagent development. |
| 11 | Histamine | 51-45-6 | Pharmaceutical R&D and biochemical detection reagent preparation. |
| 12 | Histamine Dihydrochloride | 56-92-8 | Large-scale preparation for drugs and experimental reagents. |
| 13 | Histamine Phosphate | 51-74-1 | Pharmaceutical preparation and efficient detection reagent application. |
| 14 | N-Acetyl-L-Hydroxyhistidine | 2497-02-1 | Peptide modification process and pharmaceutical intermediate R&D. |
| 15 | N-Acetyl-L-Hydroxymethyl Ester | 36097-48-0 | Pharmaceutical intermediate synthesis and organic process adaptation. |
| 16 | L-Histidine Amide Hydrochloride | 71666-95-0 | Pharmaceutical peptide synthesis R&D. |
| 17 | 3-Methyl-L-Histidine | 368-16-1 | Special drug intermediate and customized research reagent. |
| 18 | 1-Methyl-L-Histidine | 332-80-9 | Pharmaceutical intermediate R&D and scientific experiments. |
| 19 | L-Histidine Methyl Ester Dihydrochloride | 7389-87-9 | Organic synthesis process and pharmaceutical intermediate preparation. |
| 20 | D-Histidine Methyl Ester Hydrochloride | 92742-29-5 | Chiral organic synthesis and drug development. |
| 21 | D-Histidine Methyl Dihydrochloride | 4467-54-3 | Chiral pharmaceutical intermediate and synthesis process matching. |
| 22 | L-Histidine tert-Butyl Ester | 12345-72-8 | Peptide synthesis and organic synthesis R&D. |
| 23 | 3-(2-Thiophenyl)-L-Alanine Histidine Complex | 12345-69-0 | Pharmaceutical research and biochemical experiments. |
| 24 | L-Histidine L-Lactate | 12345-70-6 | Nutritional supplement and formulation raw material supply. |
| 25 | Tyrosine Histidine Hydrochloride | 94111-42-9 | Pharmaceutical R&D and biochemical reagents. |
| 26 | Benzoyl-L-Histidine Monohydrate | 5354-94-9 | Pharmaceutical intermediate and customized research reagent. |
| 27 | N-Methyl-D-Histidine Monohydrochloride | 200927-06-6 | Chiral drug synthesis and specialized reagent application. |
| 28 | N'-Methyl-L-Histidine Methyl Ester | 57519-09-2 | Pharmaceutical intermediate and organic process. |
| 29 | α-Methyl-DL-Histidine Dihydrochloride | 32381-18-3 | Scientific reagent and special synthesis. |
| 30 | N,N-Dimethyl-L-Histidine | 24940-57-6 | Pharmaceutical intermediate and scientific synthesis. |
| 31 | N,N-Dimethyl-L-Hydroxymethyl Ester | 170227-64-2 | Pharmaceutical intermediate and organic process. |
| 32 | D-Histamine Hydrochloride Monohydrate | 6341-24-8 | Chiral drug synthesis and specialized reagent. |
| 33 | 1-Benzyl-L-Histidine | 16832-24-9 | Peptide synthesis and pharmaceutical intermediate preparation. |
| 34 | N'-(Triphenylmethyl)-L-Histidine | 35146-32-8 | Peptide synthesis and amino acid protection. |
| 35 | L-Histidine Hydrochloride | 645-35-2 | Pharmaceutical preparations and scientific experiments. |
| 36 | N,N'-Di-tert-Butoxycarbonyl-L-Histidine | 20866-46-0 | Protected amino acid and peptide synthesis. |
| 37 | 1-(Triphenylmethyl)-D-Histidine | 199119-46-5 | Chiral peptide and specialized reagent. |
| 38 | N-Acetyl-N'-Triphenylmethyl-L-Histidine | 183498-47-7 | Peptide synthesis and pharmaceutical intermediate. |
| 39 | N-Triphenylmethyl-L-Histidine Methyl Ester Hydrochloride | 32946-56-8 | Peptide synthesis and organic process. |
| 40 | N-Methylhistidine Hydrochloride | 17451-62-6 | Chiral drug synthesis and specialized reagent. |
| 41 | H-Histidine AMC | 191723-64-5 | Pharmaceutical synthesis and biochemical experiment support. |
| 42 | DL-Histidine Hydrochloride Monohydrate | 123333-71-1 | Pharmaceutical preparation and scientific reagent supply. |
| 43 | Temerelin | 76712-82-8 | Peptide drug R&D and specialized pharmaceutical preparation. |
| 44 | Histamine Dihydrochloride | 15474-90-5 | Universal formulation and pharmaceutical experiment support. |
| 45 | L-Histidine Benzyl Ester p-Toluenesulfonate | 24593-59-7 | Peptide synthesis and amino acid protection. |
| 46 | CBZ-L-Histidine | 14997-58-1 | Peptide synthesis process and amino acid protection application. |
| 47 | CBZ-D-Histidine | 67424-93-5 | Chiral peptide synthesis and drug development. |
| 48 | CBZ-DL-Histidine | 19728-57-5 | General scientific synthesis and intermediate preparation. |
| 49 | CBZ-L-Histidine Methyl Ester | 15545-10-5 | Pharmaceutical intermediate synthesis and organic process adaptation. |
| 50 | CBZ-L-Histidine Benzyl Ester | 20794-07-4 | Solid-phase peptide synthesis and amino acid protection. |
| 51 | CBZ-Benzyl-L-Histidine | 21929-66-8 | High-end peptide synthesis and organic intermediate R&D. |
| 52 | Nα-CBZ-Nim-DNP-L-Histidine | 63013-46-7 | Special peptide and protected amino acid customization. |
| 53 | CBZ-O-tert-Butyl-L-Tyrosine | 5545-54-0 | Organic synthesis process and pharmaceutical intermediate preparation. |
| 54 | BOC-L-Histidine | 17791-52-5 | Peptide synthesis and amino acid protection application. |
| 55 | BOC-D-Histidine | 50654-94-9 | Chiral peptide and pharmaceutical intermediate support. |
| 56 | BOC-DL-Histidine | 121428-29-3 | General scientific synthesis and intermediate preparation supply. |
| 57 | BOC-L-Histidine Methyl Ester | 2488-14-4 | Pharmaceutical intermediate synthesis and organic process adaptation. |
| 58 | N,N'-Bis-BOC-L-Histidine | 20866-46-0 | Dual protected amino acid and peptide synthesis support. |
| 59 | N,N'-Bis-BOC-D-Histidine | 75498-93-0 | Chiral dual protected amino acid and synthesis process application. |
| 60 | N,N'-Bis-BOC-L-Histidine Methyl Ester | 17791-51-4 | Pharmaceutical intermediate R&D and peptide synthesis support. |
| 61 | BOC-N'-BOC-L-Histidine | 99310-01-7 | Peptide synthesis and amino acid protection R&D. |
| 62 | BOC-N'-Triphenylmethyl-L-Histidine | 32926-43-5 | Peptide synthesis process and protected amino acid application. |
| 63 | BOC-N'-p-Toluenesulfonyl-L-Histidine | 35899-43-5 | Peptide synthesis and amino acid protection R&D. |
| 64 | BOC-N'-p-Toluenesulfonyl-D-Histidine | 69541-68-0 | Chiral peptide and specialized reagent preparation. |
| 65 | BOC-1-Methyl-L-Histidine | 61070-20-0 | Special drug synthesis and customized research reagent. |
| 66 | BOC-3-Methyl-L-Histidine | 61070-22-2 | Pharmaceutical intermediate and peptide modification support. |
| 67 | BOC-D-Histidine (1-Methyl) | 200871-52-9 | Chiral drug synthesis and scientific reagent supply. |
| 68 | BOC-D-Histidine (3-Methyl) | 200871-84-7 | Chiral pharmaceutical intermediate and synthesis process adaptation. |
| 69 | BOC-N'-Benzyl-L-Histidine | 20898-44-6 | Peptide synthesis and amino acid protection R&D. |
| 70 | BOC-1-(Triphenylmethyl)-D-Histidine | 393568-74-6 | Chiral peptide and specialized reagent development. |
| 71 | BiBOC-D-Histidine Dicyclohexylamine | 1217849-01-8 | Chiral peptide and intermediate preparation. |
| 72 | BOC-L-Hydroxybenzyl Ester p-Toluenesulfonate | 24593-59-7 | Peptide synthesis process and amino acid protection. |
| 73 | BOC-D-Histidine (Tos)-OH·DCHA | 210694-29-4 | Chiral drug synthesis and specialized reagent matching. |
| 74 | BOC-1-CBZ-L-Histidine | 50305-43-6 | Special drug synthesis and scientific research experiment. |
| 75 | BOC-1-(2,4-Dinitrophenyl)-L-Histidine | 25024-53-7 | Chiral drug synthesis and pharmaceutical intermediate R&D. |
| 76 | Bis(tert-Butoxycarbonyl)Histidine Bis(Cyclohexylamine) Salt | 31687-58-8 | Pharmaceutical intermediate synthesis process. |
| 77 | BOC-N'-Triphenylmethyl-L-Histoyl-2-Methylanine | 2061897-68-3 | Special peptide and pharmaceutical intermediate preparation. |
| 78 | BOC-1-Triphenylmethyl-L-Histidine Methyl Ester | 62697-87-4 | Peptide synthesis R&D and organic process adaptation. |
| 79 | FMOC-L-Histidine | 116611-64-4 | High-end peptide synthesis and solid-phase process application. |
| 80 | FMOC-D-Histidine | 157355-79-8 | Chiral high-end peptide and pharmaceutical intermediate support. |
| 81 | FMOC-DL-Histidine | 157355-76-5 | Universal scientific peptide synthesis and intermediate preparation. |
| 82 | FMOC-N'-Triphenylmethyl-L-Histidine | 109425-51-6 | Solid-phase peptide synthesis and amino acid protection. |
| 83 | FMOC-N'-Triphenylmethyl-D-Histidine | 135610-90-1 | Chiral solid-phase peptide synthesis and process adaptation. |
| 84 | FMOC-3-Triphenylmethyl-L-Histidine | 128545-09-5 | High-end peptide and protected amino acid application. |
| 85 | FMOC-1-Methyl-L-Histidine | 202920-22-7 | Special peptide synthesis and pharmaceutical R&D. |
| 86 | FMOC-3-Methyl-L-Histidine | 252049-16-4 | Pharmaceutical intermediate and peptide modification support. |
| 87 | FMOC-3-Methyl-D-Histidine | 2002499-17-2 | Chiral pharmaceutical intermediate and synthesis process adaptation. |
| 88 | FMOC-N'-p-Toluenesulfonyl-L-Histidine | 112380-10-6 | Peptide synthesis and amino acid protection R&D. |
| 89 | FMOC-N'-Benzyloxymethyl-L-Histidine | 84891-19-0 | High-end peptide and protected amino acid application. |
| 90 | FMOC-N'-BOC-D-Histidine | 159631-28-4 | Chiral peptide synthesis and intermediate preparation. |
| 91 | FMOC-N'-BOC-D-Histidine Cyclohexylamine Salt | 210755-31-0 | Chiral peptide synthesis and specialized reagent supply. |
| 92 | N,1-Bis-FMOC-L-Histidine | 98929-98-7 | Dual protected peptide synthesis and special intermediate development. |
| 93 | N,1-Bis-FMOC-D-Histidine | 200926-18-7 | Chiral dual protected peptide synthesis and reagent matching. |
| 94 | FMOC-L-Hydroxyphenyl Pentafluorophenyl Ester | 109434-24-4 | Active peptide synthesis and organic coupling process. |
| 95 | FMOC-L-Histidine Allyl Ester | 220932-33-2 | Solid-phase peptide synthesis and amino acid protection. |
| 96 | FMOC-Benzyl Histidine | 84030-19-3 | High-end peptide and protected amino acid application. |
| 97 | FMOC-1-[(4-Methylphenyl)Sulfonyl]-L-Histidine | 112380-10-6 | Peptide synthesis and amino acid protection matching. |
| 98 | FMOC-N'-Triphenylmethyl-L-Histidine Pentafluorophenyl Ester | 109434-24-4 | Active peptide synthesis and organic coupling. |
| 99 | FMOC-L-Histidine (MMT)-OH | 133367-33-6 | High-end peptide and protected amino acid application. |
| 100 | FMOC-D-Histidine (Bzl)-OH | 1417638-37-9 | Chiral peptide and pharmaceutical intermediate matching. |
| 101 | FMOC-BOC Histidine | 81379-52-4 | Dual protected peptide and specialized reagent supply. |
| 102 | FMOC-N-Methyl-1-(Triphenylmethyl)-L-Histidine | 1217840-61-3 | Special peptide and pharmaceutical intermediate. |
| 103 | FMOC-N'-Triphenylmethyl-L-Histidine NCA | 151139-74-1 | Solid-phase peptide synthesis and specialized intermediate. |
| 104 | 1-BOC-N-FMOC-L-Histidine Cyclohexylammonium Salt | 210820-99-8 | Dual protected peptide synthesis and reagent matching. |
| 105 | N-(9-Fluorenylmethoxycarbonyl)-N'-(4-Methyltriphenylmethyl)-D-Histidine | 200926-19-8 | Chiral high-end peptide and intermediate. |